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Shigella flexneri invades colonic epithelial cells by pathogen-induced phagocytosis. The three proposed
effectors of S. flexneri internalization are invasion plasmid antigens B (IpaB), IpaC, and IpaD, which are
encoded on the pathogen’s 230-kb virulence plasmid and translocated to the extracellular milieu via the
Mxi-Spa translocon. To date, there are no definitive functional data for any purified Ipa protein. Here, we
describe the first characterization of highly purified recombinant IpaC, which elicits numerous epithelial cell
responses related to events that take place during pathogen invasion. 125I-labeled IpaC binds cultured Henle
407 intestinal cells with an apparent dissociation constant in the low micromolar range. Moreover, incubation
of epithelial cells with IpaC results in general changes in cellular phosphoprotein content, demonstrating this
protein’s ability to influence cellular protein kinase activities. These results contrast dramatically with those
seen for recombinant IpaD, which does not bind to or induce detectable changes in the normal activities of
cultured epithelial cells. In addition to influencing host cell activities, preincubation of epithelial cells with
purified IpaC enhances uptake of S. flexneri by host cells. A similar result is seen when the cells are
preincubated with a highly concentrated water extract of virulent S. flexneri 2a (strain 2457T). Interestingly,
soluble IpaC also appears to promote uptake of the noninvasive S. flexneri 2a strain BS103. Purified IpaD failed
to enhance the uptake of virulent S. flexneri and did not facilitate uptake of BS103. Taken together, the data
suggest that IpaC is a potential effector of the host cell biological activities and may be responsible for entry
of S. flexneri into target cells.
Shigella flexneri is a gram-negative bacillus responsible for
bacillary dysentery, an important cause of infant mortality in
underdeveloped regions of the world. Establishment of infec-
tion by S. flexneri is characterized by (i) bacterial invasion of
the colonic epithelium (14), (ii) intracellular movement and
multiplication of the pathogen (3, 31), and (iii) direct infection
of neighboring epithelial cells (also called intercellular spread)
(3, 16, 30). Localized trauma results as S. flexneri invasion of
the colonic epithelium elicits localized cell death and inflam-
mation (8). These events ultimately lead to the overt manifes-
tations of dysentery, which include fever, abdominal cramping,
and scanty, loose stools containing mucus and blood (8).
Initial invasion by S. flexneri resembles phagocytosis and has
thus been called “pathogen-induced phagocytosis” (4, 5). Up-
take of S. flexneri occurs when the pathogen stimulates local-
ized accumulation of filamentous actin and myosin at the inner
face of the host cytoplasmic membrane at the site of bacterial
contact (4). Both the pathogen and the host cell actively con-
tribute to this process (9, 10), and subsequent lysis of the
resulting phagocytic vacuole allows the bacterium to gain ac-
cess to the target cell cytoplasm (11, 31).
All the determinants necessary for mediating S. flexneri in-
vasion are located on a 31-kb fragment of this pathogen’s large
virulence plasmid (19, 33). An important region within this
fragment contains an operon encoding four polypeptides that
are major targets of the host humoral immune response during
S. flexneri infection (26). These proteins are the invasion plas-
mid antigens (Ipa proteins) and include IpaA (70 kDa), IpaB
(62 kDa), IpaC (42 kDa), and IpaD (38 kDa) (26, 32). Syn-
thesis of IpaB, IpaC, and IpaD is required for the S. flexneri
invasive phenotype (21), as is the transport of these invasins to
the bacterial surface and/or the external medium via products
of the mxi and spa operons (1, 2, 22, 28, 37, 39).
Well-characterized nonpolar mutants possessing inactivated
forms of either IpaB, IpaC, or IpaD have been instrumental in
providing initial evidence for the importance of these proteins
in the S. flexneri entry mechanism (21). Complementation anal-
yses have further implicated IpaB as a participant in bacterial
internalization and lysis of the resulting phagosomal mem-
brane (11). Additional evidence linking IpaB and IpaC with
the invasion process was provided by studies in which mono-
clonal antibodies known to bind specific epitopes on these
proteins were shown to influence the ability of S. flexneri to
invade epithelial cell monolayers (24, 34). With further infor-
mation that IpaC possesses immunogenic domains that may
have important roles in determining disease outcome following
exposure to Shigella spp. (35), it is becoming clear that the Ipa
proteins, IpaB and IpaC in particular, contribute directly to the
onset of shigellosis. Unfortunately, no biochemical data are yet
available to define the roles of the individual Ipa proteins in
pathogen uptake, and few studies have been initiated to inves-
tigate directly the individual in vitro activities of these invasins
(18).
It was recently suggested that the Ipa proteins are rapidly
secreted from the S. flexneri outer membrane and from intra-
cellular stores upon incubation of the bacterium with epithelial
cells (22, 28, 39, 40). In these studies, IpaB and IpaC were
found to exist as part of a secreted protein complex (23, 28).
IpaD was not found to associate significantly with the extra-
cellular IpaB-IpaC complex and was proposed to function as a
transient effector of IpaB secretion within the context of the
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Mxi-Spa translocon (28). The latter suggestion was based upon
observations that IpaD appeared to form a complex with IpaB
but only within the S. flexneri membrane (22). The putative
extracellular IpaB-IpaC complex has been proposed to medi-
ate pathogen entry (20, 22, 23, 39, 40), possibly through bind-
ing of a5b1 integrin receptors (38). After binding, the Ipa
complex may induce signaling cascades that trigger changes in
target cell protein kinase activities (6, 38) and promote lysis of
the resulting phagosomal membrane (11). Unfortunately, no
invasion-related biochemical activity has yet been attributed to
a purified form of any of the Ipa proteins, thus compromising
definitive assignment of specific roles for any of these invasins.
Here, we provide the first report of possible invasion-related
activities for a highly purified recombinant Ipa protein. The
ipaC and ipaD genes (18, 29) were cloned from the invasion
plasmid of S. flexneri and inserted into a plasmid expression
vector. Following expression, each was purified and its effects
on cultured epithelial cells were investigated. IpaD had no
detectable activity in any of these experiments; however, IpaC
was found to specifically bind epithelial cells and induce a
number of cellular responses. These responses are believed to
be related to IpaC-mediated events occurring in the S. flexneri
internalization process.
MATERIALS AND METHODS
Materials. Na125I and [32P]orthophosphoric acid in water were obtained from
New England Nuclear (Boston, Mass.); 1,3,4,6-tetrachloro-3a,6a-diphenylgly-
couril was from Sigma Chemical Co. (St. Louis, Mo.). Dulbecco’s modified
Eagle’s medium was from Gibco-BRL (Grand Island, N.Y.), and Eagle’s mod-
ified minimal essential medium (MEME) was from Fisher Scientific (St. Louis,
Mo.). All other chemicals were of reagent grade.
Growth and maintenance of cultures. S. flexneri 2a (strain 2457T) was provided
by A. T. Maurelli (Uniformed Services University of the Health Sciences, Be-
thesda, Md.) and routinely grown at 378C on Trypticase soy agar containing
0.025% Congo red. Where stated, S. flexneri 2a which had been cured of its
invasion plasmid (strain BS103) was used and similarly maintained. The latter
strain appeared white on Congo red plates, while strain 2457T appeared red on
this medium because of the crb locus (8). The plasmid expression vectors
pWPD10 (ipaD/pET15b) and ipaC/pET15b (now called pWPC15) were main-
tained in Escherichia coli BL21(DE3)(pLysS) (Novagen, Madison, Wis.), which
is routinely grown at 378C in Luria-Bertani broth containing 50 mg of ampicillin
per ml. Henle 407 epithelial cells (ATCC CCL6) were routinely grown in mono-
layers with 5% CO2 in MEME supplemented with 10% newborn calf serum.
Plasmid construction. Construction of pWPD10 has been described previously
(18), and ipaC-containing pET15b (pWPC15) was constructed as described else-
where (29). Briefly, PCR primers based on published sequences (36) were made
to copy the ipa gene from the virulence plasmid of S. flexneri 2a strain 2457T. In
the case of pWPD10, the gene fragment was digested with NdeI and BamHI and
inserted into NdeI-BamHI-digested pET15b from Novagen. In the case of
pWPC15, the ipa PCR fragment was first trapped in the pCRII plasmid of
Invitrogen (San Diego, Calif.) and then subcloned into pET15b. For expression
of the recombinant protein, each plasmid was transformed into E. coli
BL21(DE3)(pLysS).
Purification of recombinant Ipa proteins. Recombinant HisTag-IpaC was
expressed by inducing early-log-phase cultures of BL21(DE3)(pLysS) containing
pWPC15 with 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG). Cultures were
grown at 308C with mild shaking (150 rpm) to slow bacterial growth, thereby
enhancing the yield of IpaC expressed in a soluble form (29). After 2 h, the
bacteria were harvested by centrifugation, resuspended in column binding buffer
(5 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl [pH 7.9]), and sonicated,
and the resulting lysate was clarified by centrifugation at 39,000 3 g for 20 min.
The resulting IpaC (or IpaD) fusion protein was purified by virtue of its short
leader peptide which contains six tandem histidine residues for HisBind (Ni21-
chelation resin) affinity column chromatography according to the instructions of
the manufacturer (Novagen). Following elution with imidazole, purified IpaC
was dialyzed against phosphate-buffered saline (PBS) (10 mM sodium phosphate
[pH 7.2] containing 150 mM NaCl). Protein concentrations were determined by
bicinchoninic acid microprotein determination (Sigma Chemical Co.).
Immunoblot analysis of the Ipa proteins. The identification of Ipa proteins in
purified protein preparations, or in water extracts of virulent S. flexneri (26),
could be carried out by immunoblot analysis as described previously (18). Briefly,
proteins were first separated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) by the method of Laemmli (15) and electrophoreti-
cally transferred to a polyvinylidene difluoride membrane with a Transblot semi-
dry blotting apparatus (Bio-Rad, Madison, Wis.). The membrane was incubated
with 3% nonfat dried milk in 20 mM Tris-HCl containing 150 mM NaCl (TBS)
to block nonspecific protein binding sites. The blots were then incubated with
antibody diluted in TBS containing 0.05% Nonidet P-40. Monkey prechallenge
and convalescent-phase sera, monoclonal antibody to IpaC (2G2), and poly-
clonal rabbit serum to IpaD were provided by E. V. Oaks (Walter Reed Army
Institute for Research, Washington, D.C.). After being washed in TBS contain-
ing Nonidet P-40, the membranes were incubated with 125I-labeled protein G.
The membranes were washed in TBS containing 1 M NaCl and 4% sodium
N-lauroylsarcosine and exposed to X-ray film for autoradiography.
Changes in the phosphorylation of host cell proteins in the presence of IpaC.
To monitor Ipa protein effects on host cell protein kinase activities (6), Henle
407 cells in 25-cm2 flasks (approximately 43 106 cells) were incubated for 30 min
in 2 ml of high-glucose Dulbecco’s modified Eagle’s medium lacking phosphate
which was supplemented with 50 mCi of [32P]orthophosphoric acid. Next, PBS
alone or PBS containing IpaC or IpaD (1 ml) was added to the monolayers, and
the flasks were incubated for another 30 min at 378C. The flasks were placed on
ice, and the cells were washed three times with 2 ml of ice-cold PBS. The cells
were then scraped into 1 ml of PBS, collected by centrifugation, and resuspended
in 200 ml of water to which 200 ml of 23 SDS-PAGE sample buffer was added.
The samples were boiled for 5 min, and 25 mg of protein was separated on an
SDS–10% polyacrylamide gel. The gel was stained with Coomassie blue R250,
destained, dried, and exposed to X-ray film. Qualitative changes in the phospho-
protein profile of the cells could be observed by autoradiography.
Protein binding to cultured epithelial cells. To examine the ability of IpaC or
IpaD to associate with cultured Henle 407 cells, each protein was labeled with
125I by a standard protocol for iodination using 1,3,4,6-tetrachloro-3a,6a-diphe-
nylglycouril (7). Radiolabeled IpaD or IpaC was incubated for 30 min with
monolayers of Henle 407 cells seeded on 24-well culture plates (approximately
23 105 cells per well). The amount of radiolabeled protein bound to the cells (on
a per-cell basis) was monitored by washing the cells extensively with PBS and
determining the radioactivity present in a uniformly distributed cell suspension
incubated with 0.25% trypsin. Similar results were obtained when the cells were
solubilized with 1% Triton X-100 in water (data not shown).
Assay of S. flexneri uptake by cultured epithelial cells. Uptake assays were
performed essentially by the method of Niesel et al. (25). Henle 407 cells were
grown to near confluence in 24-well tissue culture plates. S. flexneri 2a strain
2457T, grown to an A600 of about 0.4, was diluted with MEME containing 0.67
mg of FeCl3 per ml and 0.45% glucose (MEME-Fe) so that a final multiplicity of
infection (MOI) of about 3 was reached. To each well containing Henle 407 cells,
MEME-Fe was added alone or with increasing concentrations of protein ex-
tracted from the surface of S. flexneri cells with water (water-extracted Shigella
proteins) (26), IpaD or IpaC. The cells were incubated for 30 min at 378C, after
which the liquid was removed by aspiration. S. flexneri organisms (in 250 ml of
MEME-Fe) were added and incubated with the cells for 30 min at 378C. Fol-
lowing incubation, the bacterial suspension was removed by aspiration, and the
cells were washed six times with MEME containing 5% newborn calf serum and
40 mg of gentamicin per ml (with a 1-min incubation during each wash). The cells
were then incubated with the last gentamicin-containing wash for 2 h prior to its
removal. This treatment killed the bacteria remaining exposed to the medium
but not those that had been internalized. The cells were then rinsed with
MEME-Fe lacking serum and gentamicin. Each monolayer was overlaid with 250
ml of 0.5% agarose. After solidification, the agarose was overlaid with 0.5% agar
containing 23 Luria-Bertani medium. The plate was then incubated at room
temperature for 30 min and inverted for incubation at 378C overnight. The S.
flexneri cells protected from gentamicin because of uptake by the Henle 407 cells
were seen as subsurface colonies and counted with a dissecting microscope. This
uptake assay was also used with the noninvasive S. flexneri 2a strain BS103 to
investigate the ability of IpaC to promote entry of a noninvasive bacterium. The
same assay could be modified to monitor S. flexneri binding to Henle 407 cells by
omitting gentamicin from the wash steps. It should be pointed out, however, that
this modification of the assay does not distinguish between bacteria adhering to
the surface of the Henle 407 cells and organisms adhering to open spaces on the
surface of the culture dish.
RESULTS
Preparation of recombinant IpaC and IpaD. After transfor-
mation of E. coli BL21(DE3)(pLysS) with pWPC15 (or
pWPD10), high-level expression of IpaC (or IpaD) could be
induced with IPTG and seen by SDS-PAGE with Coomassie
staining (Fig. 1A). Because each protein possesses a short
leader peptide containing six consecutive histidine residues, it
was possible to affinity purify each overexpressed protein prod-
uct on a Ni21 chelation resin (Fig. 1A, lanes 3 and 4). In
samples of purified IpaC, the full-size IpaC product was visible
as the major protein product on Coomassie-stained gels, with
a molecular mass of about 45 kDa. Also visible are some
smaller protein products which are stable IpaC degradation
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products (see below). Identification of purified IpaC and IpaD
was carried out by immunoblot analysis using anti-IpaC mono-
clonal antibody (2G2) or rabbit polyclonal antiserum raised
against synthetic peptides from IpaD (Fig. 1B). The purified
antigens were also seen to react with sera from convalescent-
phase monkeys but not with sera from the same monkeys prior
to challenge with S. flexneri (data not shown). Moreover, the
2G2 monoclonal antibody reacted with the small polypeptides
present in the IpaC sample (Fig. 1B), which indicates that
these are stable IpaC degradation products. Degradation prod-
ucts of a similar size were seen when the same monoclonal
antibody preparation was used with concentrated S. flexneri 2a
water-extracted proteins (data not shown). It is not yet known
if the presence of the predominant IpaC degradation product
(about 25 to 30 kDa) has any link to S. flexneri pathogenesis.
Binding of 125I-labeled IpaC to Henle 407 cells. An effector
of the host cell events that lead to pathogen-induced phago-
cytosis would be anticipated to interact in some way with the
host cell, most likely through a specific receptor-ligand inter-
action. To determine whether Henle 407 cells can interact with
IpaD or IpaC, each protein was radioiodinated and its binding
to these cells was monitored. There did not appear to be a
significant interaction between 125I-IpaD and the cell mono-
layers (Fig. 2A), and the minor amount of IpaD binding that
was observed did not appear to saturate within the IpaD con-
centration range examined (giving an apparent dissociation
constant [Kd] near 0.5 mM). In contrast,
125I-IpaC bound well
to the cells (Fig. 2A) and had an apparent dissociation constant
near 5 mM. To test the specificity of 125I-IpaC association with
Henle 407 cells, unlabeled IpaC and IpaD were used as com-
petitive inhibitors of 125I-IpaC binding. While excess unlabeled
IpaC was found to effectively block the binding of 125I-IpaC,
IpaD had no effect on this binding (Fig. 2B). The specific
interaction of IpaC with the surface of epithelial cells suggests
that IpaC is involved in the early steps of host cell invasion.
Changes in cellular phosphoprotein profile. It has been sug-
gested that an early event in the uptake of S. flexneri by epi-
thelial cells is the stimulation of host cell tyrosine kinase ac-
tivities (6). The observation that IpaC binds to epithelial cells
indicates that this important S. flexneri virulence protein may
be capable of triggering specific signal transduction pathways.
Because protein phosphorylation events have been postulated
to play a role in host cell signaling during S. flexneri invasion,
IpaC was incubated with Henle 407 cells and changes in the
cellular profile of phosphoproteins were examined. In these
experiments, the cells were incubated in phosphate-free
MEME to which 32Pi was added. After a 30-min incubation (to
allow equilibration of the cells with the radioactive phosphate),
either PBS alone or PBS containing IpaC or IpaD was added
to the medium and the cells were incubated for another 30
min. At the end of the second incubation, the profile of phos-
phorylated proteins was monitored by separating the cellular
proteins by SDS-PAGE and using the dried gel for autoradiog-
raphy. IpaD had only a minor effect on the phosphoprotein
profile of the Henle 407 cells relative to that of control cells
incubated with PBS (Fig. 3). In contrast, IpaC caused a major
decrease in the overall extent of protein phosphorylation in the
cells which was not accompanied by any apparent qualitative
change in the phosphoprotein profile (Fig. 3). These results
FIG. 1. Expression and purification of IpaC and IpaD. E. coli
BL21(DE3)(pLysS) was transformed with plasmid pET15b containing ipaC
(pWPC15) or ipaD (pWPD10). (A) Coomassie-stained SDS–10% polyacryl-
amide gel. Lane 1, whole cells harboring pWPC15 prior to induction of recom-
binant protein synthesis; lane 2, extract of cells containing pWPC15 after 2 h of
induction with IPTG; lane 3, recombinant IpaC following purification on the
HisTag-resin; and lane 4, IpaD following its purification by the same method.
Molecular masses (in kilodaltons) are shown on the left. (B) The purified IpaC
(lane 1) and purified IpaD (lane 2) were analyzed by immunoblotting with an
anti-IpaC monoclonal antibody (2G2) or polyclonal antibodies prepared against
synthetic peptides from IpaD.
FIG. 2. IpaC and IpaD were labeled with 125I so that their association with Henle 407 cells could be monitored. Radioiodinated protein (specific activity 5 106
cpm/mg) was incubated for 30 min with monolayers of Henle 407 cells (2 3 105) seeded onto 24-well plates. Following the incubation, the monolayers were washed
five times with PBS. The cells were then released from their monolayers with 0.25% trypsin, and aliquots of a uniform cell suspension were used to determine the counts
per minute that had remained with the cells after extensive washing. The concentration of IpaC or IpaD that remained with the cells was determined on the basis of
the known molecular weight of each protein and the known amount of protein (in micrograms) incubated in each well. (A) Binding of 125I-IpaC to the cells (open
symbols) and binding of 125I-IpaD (closed symbols). The points given are an average of four samples (6 standard error [SE]). (B) The binding of approximately 300
fmol of 125I-IpaC was competitively blocked by adding excess unlabeled IpaC (open symbols). In contrast, 125I-IpaC binding was essentially unaffected by adding excess
unlabeled IpaD (closed symbols). The points shown are an average of four samples 6 SE.
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provide evidence that IpaC exerts effects on Henle 407 cells
that influence intracellular signaling processes. Interestingly,
no such obvious effect on the cellular phosphoprotein content
was seen when the Henle 407 cells were incubated with intact
virulent S. flexneri at an MOI of 5 (Fig. 3). The latter obser-
vations could be due to the relative concentration of IpaC in
the S. flexneri sample or due to the presence of factors associ-
ated with the intact pathogen that temper or modify the activ-
ity of IpaC. At a higher MOI, S. flexneri did cause a general
decrease in Henle 407 cell phosphoprotein content (data not
shown); however, this was accompanied by an increase in cell
killing. IpaC was not found to be cytotoxic to the cells as
determined by exclusion of trypan blue.
IpaC effects on the uptake of S. flexneri by Henle 407 cells.
To further investigate the role of IpaC as a soluble invasin,
Henle 407 cells were preincubated with PBS alone or with PBS
containing IpaD, IpaC, or proteins extracted from S. flexneri 2a
with water, so that the influence each preparation has on sub-
sequent pathogen uptake could be determined. Preincubation
of the cells with micromolar concentrations of IpaC enhanced
the apparent uptake of S. flexneri (Fig. 4). Because the assay
used measures the protection of bacteria from gentamicin,
these results are interpreted to reflect an enhancement of
pathogen uptake via macropinocytosis; however, it is also pos-
sible that protection from gentamicin occurs as bacteria be-
come trapped within membrane folds that form on the host cell
surface in response to IpaC binding. Either possibility suggests
that IpaC evokes host cell changes that contribute to invasion.
A similar event was observed when Henle 407 cells were pre-
incubated with concentrated water extracts of S. flexneri 2a
(Fig. 4), while no such effect was seen when any concentration
of IpaD was preincubated with the epithelial cells (Fig. 4).
To further investigate this phenomenon, the effect of IpaC
on S. flexneri adherence to Henle 407 cells was monitored and
also found to be enhanced (from 620 to 1,364 adherent organ-
isms per well at an MOI of 0.3; average of three wells). These
data complicated matters in that increased adherence of viru-
lent S. flexneri organisms (capable of facilitating their own
invasion following IpaC-mediated host cell binding) could per-
haps account entirely for the enhanced internalization of the
pathogen. To determine whether pathogen binding alone
could explain the enhancement of uptake of internalized or-
ganisms, noninvasive S. flexneri 2a strain BS103 was added to
the Henle 407 cells after they had been incubated with IpaC to
determine if uptake of these cells could be achieved. Indeed,
preincubation of the epithelial cells with IpaC promoted up-
take of BS103, albeit at a much lower rate than that of 2457T
(Fig. 5). IpaD was not able to stimulate the uptake of BS103
FIG. 3. Changes in the phosphoprotein content of Henle 407 cells caused by
incubation with IpaC. Henle 407 cells were incubated for 30 min in 2 ml of PBS
containing 50 mCi of 32Pi. The Henle 407 cells were then incubated for another
30 min following the addition of 1 ml of PBS (lane 1) or PBS containing IpaC
(lane 2), IpaD (lane 3), or intact virulent S. flexneri 2a (lane 4). The cells were
then washed, scraped loose from the monolayers, pelleted by mild centrifugation,
and lysed by adding 200 ml of water, 200 ml of SDS sample buffer, and 10 ml of
b-mercaptoethanol. (A) The proteins in the sample (50 mg of protein) were
separated by SDS-PAGE. The gels were stained with Coomassie blue R250 so
that the amounts of protein in the lanes could be compared. (B) The dried gels
were exposed to X-ray film to monitor the phosphoprotein profile in each lane.
Molecular masses (in kilodaltons) are shown on the left.
FIG. 4. S. flexneri 2a invasion of Henle 407 cell monolayers in 24-well culture
plates monitored as a function of increasing concentrations of IpaC, IpaD, or
proteins extracted from intact virulent S. flexneri 2a with water and dialyzed
against PBS. The cells were preincubated for 30 min with PBS alone or PBS
containing IpaC, IpaD, or water-extracted proteins. The cells were then rinsed,
and 250 ml of MEME-Fe containing S. flexneri 2a was added to give an MOI of
3. The bacteria were incubated with the cells for 30 min, and the monolayers
were then washed with MEME containing gentamicin. After being washed, the
cells were overlaid with agarose and then agar containing 23 Luria-Bertani
medium. The effect of preincubation on invasion was determined by comparison
with controls in which either no Shigella organisms (negative control) were added
or in which Shigella organisms were added but the preincubation mixture did not
contain any test protein (positive control). The values given are the averages
(6SE) of five experiments, with 100% invasion being 116 colonies (631). Sta-
tistical significances of differences relative to the control (Cont.) sample (using
the Student’s t test) were P , 0.1 for 50 mg of IpaC and 50 mg of water extract
protein, P , 0.05 for 100 mg of water extract protein, and P , 0.01 for 100 mg
of IpaC.
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and had no effect on the adherence of 2457T. These data
suggest that purified recombinant IpaC is capable of inducing
uptake of a noninvasive strain of S. flexneri, further indicating
the importance of IpaC as a major component of the invasive-
ness apparatus of S. flexneri.
DISCUSSION
S. flexneri and related species are major causes of morbidity
and mortality in humans, particularly children, around the
world. The low dose of organisms required for the establish-
ment of infection makes shigellosis a particularly vexing health
problem for a major segment of the world’s population. A
detailed description of the biochemistry of this organism’s
pathogenesis would provide a major step toward developing
measures for the treatment and prevention of shigellosis.
Genetic analyses have demonstrated that the invasive phe-
notype of S. flexneri requires secretion of IpaB, IpaC, and IpaD
via a type III (Mxi-Spa) secretory pathway (22). Inactivation of
ipaB, ipaC, or ipaD or interference with the secretion of their
gene products is sufficient for elimination of the S. flexneri
invasive phenotype (1, 2, 22, 28, 39). Following their secretion,
IpaB and IpaC form a complex that is postulated to be of
importance in invasion (20, 22, 28). Indeed, when this complex
is immunoadsorbed from a crude mixture of proteins to the
surface of latex beads, the uptake of these particles by epithe-
lial cells appears to be stimulated (20). While these data were
interpreted to demonstrate the importance of soluble IpaB-
IpaC complexes in the pathogenesis of S. flexneri, they perhaps
better represent what would occur if the Ipa proteins were
immobilized at the pathogen surface. In this respect, the IpaB-
IpaC complex appears to mimic invasin from Yersinia pseudo-
tuberculosis (12) except that the latter promotes internalization
by a zippering mechanism while the IpaB-IpaC complex pro-
motes uptake via a less well defined mechanism (20). Watarai
and coworkers found that a culture filtrate containing soluble
Ipa proteins could stimulate the uptake of noninvasive spa32
mutants of S. flexneri 2a but not plasmid-cured S. flexneri 2a
(39). Interestingly, the spa32 mutants are able to expose the
Ipa proteins on the bacterial surface but are unable to release
these proteins into the surrounding medium (39). In this re-
spect, the spa32 mutant resembles Ipa protein-coated latex
beads except that the coated beads are able to enter HeLa cells
while the spa32 mutants are not able to enter MK2 cells except
in the presence of Ipa protein-containing culture filtrates (20,
39). These apparently contradictory results further demon-
strate the complexity of the S. flexneri invasion mechanism and
underscore the need for functional analyses using purified
forms of the Ipa proteins.
There are currently no functional data available that pre-
cisely define the role of an individual Ipa protein in S. flexneri
invasion. To alleviate this oversight, we have cloned, expressed,
and purified IpaB, IpaC, and IpaD from S. flexneri 2a to study
the in vitro biochemical properties of these proteins (29).
Here, we report the first direct evidence of a biological activity
for IpaC which relates to the invasion of Henle 407 cells by S.
flexneri. Purified recombinant IpaC binds epithelial cells to
trigger changes in host phosphoprotein content and uptake of
S. flexneri 2a (strain 2457T). Moreover, preincubation of the
epithelial cells with recombinant IpaC causes the apparent
uptake of the noninvasive BS103 strain of S. flexneri 2a. None
of these properties were observed for an identically prepared
recombinant form of IpaD. The fact that IpaC stimulates up-
take of a noninvasive bacterium strongly suggests a prominent
role for this antigen in the initial stages of pathogen internal-
ization.
The action of the Ipa invasins is dependent upon their sur-
face localization and subsequent release from surface and cy-
toplasmic stores via the Mxi-Spa translocon system (1, 22, 37).
It is perhaps not surprising that a highly concentrated water
extract of S. flexneri enhances invasion by this pathogen via
secreted invasins. This is consistent with a model in which the
action of the secreted Ipa invasins is highly concentration de-
pendent. Release of IpaB and IpaC upon contact with epithe-
lial cells would result in localized high concentrations of these
invasins over a relatively small area of the host cell surface.
These high concentrations would be required to elicit the host
cell cytoskeletal changes that are ultimately responsible for
pathogen internalization (4, 5). Once the pathogens are en-
closed in a macropinocytotic vesicle, further Ipa protein secre-
tion would result in the massive accumulation of Ipa protein
within the confines of the vesicle, which could be a prerequisite
for lysis of the phagosomal membrane. Such a model is con-
sistent with the need for contact between S. flexneri and eryth-
rocytes to elicit an otherwise inefficient hemolysis (11, 31; un-
published observations) and with the need for relatively high
concentrations of IpaC (in the micromolar range) for eliciting
the observed effects in cultured cells. Interestingly, this rela-
tively large Kd is consistent with associations that involve inte-
grin receptors which have recently been proposed as being the
Ipa protein receptor (38).
Possibly the most curious finding presented here is that
incubation of Henle 407 cells with IpaC results in an overall
decrease in cellular protein phosphorylation. Previous studies
have implicated increased tyrosine phosphorylation of pp60src
targets in the early stages of S. flexneri internalization (6, 38).
At first glance, the results presented here appear to be in
conflict with these previous findings (although this study does
implicate changes in cellular protein phosphorylation in the
action of an Ipa invasin). It is possible, however, that the high
concentrations of IpaC used here, although not toxic to the
host cell, may overload intracellular signaling processes and
result in an apparent diminution of protein phosphorylation in
general. This would be consistent with recent observations that
invasion of HeLa cells by S. flexneri causes a decrease in the
intracellular pools of nucleotide triphosphates (17).
Taken together, the data presented here provide exciting
FIG. 5. Purified IpaC induces invasion of Henle 407 cells by S. flexneri 2a
strain BS103. The same invasion assay as used for Fig. 4 was carried out except
that noninvasive S. flexneri strain BS103 (cured of the virulence plasmid) was
used. Controls (Cont.) containing either no protein in the preincubation mix or
no Shigella organisms in the subsequent incubation had no growth. The graph
shows the number of invasive bacteria (averages of six experiments 6 SE) seen
for each concentration of IpaC or IpaD.
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new information on the cell biology of S. flexneri invasion. It
will now be interesting to examine the biochemical properties
of highly purified recombinant IpaB for comparison with the
findings presented here and with findings on the function of a
reconstituted IpaB-IpaC complex. Furthermore, the door is
now open to more sensitively investigate the complex immu-
nobiology of shigellosis. Studies of the host immune response
to IpaD have revealed that this protein antigen may provide an
extremely useful tool for the immunosurveillance of Shigella
infections (27). Now, with findings that host immune recogni-
tion of specific epitopes on IpaC may be correlated with dis-
ease onset, it may be possible to use IpaB, IpaC, and IpaD to
create a battery of immunodiagnostic tools for testing the ef-
ficacy of the live oral vaccines that are being developed (13).
Perhaps it will even be possible to augment available live oral
vaccines by using purified preparations of these recombinant
Ipa invasins.
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